Benzinga

Adam Feuerstein sees major price manipulation in small-cap pharma stocks

Adam Feuerstein sees major price manipulation in small-cap pharma stocks

Senior columnist at The Street Adam Feuerstein explains his ongoing campaign against "low-floater" biotech stocks as well as companies in the sector that he is more favorable toward. Listen to PreMarket Prep and chat LIVE with our hosts, guests, and other listeners every weekday morning from 8-9 ET! premarket.benzinga.com/pre-market-show/

Duration: 13 min

Release Date:

Share part or all of the audio of this episode